Fortrea Holdings Inc has introduced Fortrea Intelligent Technology™ (FIT), an AI-powered suite designed to transform clinical trial operations for sponsors, research centers, and study teams. FIT automates workflows, simplifies oversight, and delivers near real-time, role-based insights through its flagship platform Xcellerate®, improving trial speed, predictability, and quality. The technology supports full lifecycle trial management, proactive data-driven decision-making, and enhanced collaboration, aiming to accelerate the delivery of life-changing therapies. Fortrea plans to expand this technology suite with additional solutions in the future.
Christopher Derrick, known for writing on Star Trek: Picard and The Equalizer, premieres his first film as sole writer-director, Moral Dirt, at the Academy Award® Qualifying LA Shorts International Film Festival on August 3, 2026. The 15-minute psych...
Arcutis Biotherapeutics has appointed Chris Peetz to its Board of Directors as of July 15, 2026. Peetz brings extensive experience leading biopharmaceutical companies through growth phases, product development, and strategic acquisitions. His additio...
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
